The Fraser Institute: Media Advisory; How Do Delays in Approving New Cancer Medicines Affect Patients? New Study Coming Thursday, November 7
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 11/06/13 -- The Fraser Institute will release a new study Thursday November 7 examining how delays in approving five new oncology drugs affected Canadian patients.
The study, Potential Patients Impacted by Delayed Access to Five Oncology Drugs in Canada by Nigel Rawson, PhD., looks at:
A news release with additional information will be issued via Marketwired at 6:30 a.m. (Eastern) on Thursday, November 7.
The full report will also be available as a free PDF download at .
Follow the Fraser Institute on and
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of 86 think-tanks. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit .
Contacts:
The Fraser Institute
Nigel Rawson, Ph.D.
Senior Fellow
(289) 838-9855
The Fraser Institute
Dean Pelkey
Director of Communications
(604) 714-4582
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.11.2013 - 13:15 Uhr
Sprache: Deutsch
News-ID 313328
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Associations
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Fraser Institute: Media Advisory; How Do Delays in Approving New Cancer Medicines Affect Patients? New Study Coming Thursday, November 7"
steht unter der journalistisch-redaktionellen Verantwortung von
The Fraser Institute (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
